Wegovy craze was all the rage on Q3 earnings calls
By Bhanvi Satija and Savyata Mishra (Reuters) – Weight loss was the talk of this earnings season, making names such as Wegovy, Ozempic and Mounjaro the water-cooler discussion that companies across the…
Nestle shares at two-year low as investors weigh Wegovy rollout
(Reuters) – Nestle shares were under pressure on Friday as investors weighed the potential impact of Novo Nordisk’s blockbuster weight-losing drug Wegovy and how it could reduce spending on food. The KitKat…
US Patent Office won’t review two Novo Nordisk patents for Wegovy, Ozempic
By Blake Brittain WASHINGTON (Reuters) – A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its weight-loss and diabetes…
Exclusive-Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug-sources
By Maggie Fick LONDON (Reuters) – Catalent’s plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk’s weight-loss drug Wegovy as part of the two companies’ expanded supply agreement, two sources…
US psychiatrists prescribe Wegovy to battle medication-induced weight gain
By Elissa Welle NEW YORK (Reuters) – U.S. psychiatrists are increasingly prescribing the popular weight-loss drug Wegovy to patients who gain weight from medicines used to treat mental disorders, such as schizophrenia…
Weight-loss drug pioneers aim to jump on Wegovy bandwagon
By Jennifer Rigby DUBLIN (Reuters) – Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing treatments are hoping the resulting demand will boost demand for their older,…
Breaking News
